Terheyden P, Weishaupt C, Heinzerling L, Klinkhardt U, Krauss J, Mohr P, Kiecker F, Becker JC, Submitter AD, Doener F, Heidenreich R, Scheel B, Schoenborn-Kellenberger O, Seibel T, Gnad-Vogt U (2018)
Publication Type: Conference contribution
Publication year: 2018
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: 466-466
Conference Proceedings Title: ANNALS OF ONCOLOGY
DOI: 10.1093/annonc/mdy289.061
APA:
Terheyden, P., Weishaupt, C., Heinzerling, L., Klinkhardt, U., Krauss, J., Mohr, P.,... Gnad-Vogt, U. (2018). Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- nd RIG-1 agonist in patients with advanced solid tumors. In ANNALS OF ONCOLOGY (pp. 466-466). Munich, DE: OXFORD: OXFORD UNIV PRESS.
MLA:
Terheyden, P., et al. "Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- nd RIG-1 agonist in patients with advanced solid tumors." Proceedings of the 43rd ESMO Congress (ESMO), Munich OXFORD: OXFORD UNIV PRESS, 2018. 466-466.
BibTeX: Download